Import and fate of fluorescent analogs of oxidized phospholipids in vascular smooth muscle cells

Journal of Lipid Research

Volumn 48, Issue 3, 2007, Pages 565-582

  Moumtzi, Alexandra ^a   Trenker, Michael ^a   Flicker, Karlheinz ^a   Zenzmaier, Elfriede ^a   Saf, Robert ^b   Hermetter, Albin ^a  

^a GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^b GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Atherosclerosis; Lipid synthesis; Lipid transport; Lipoproteins

Indexed keywords

1 PALMITOYL 2 (5 OXOVALEROYL)GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 GLUTAROYL GLYCERO 3 PHOSPHOCHOLINE; PHOSPHORYLCHOLINE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CHEMICAL INTERACTION; CONTROLLED STUDY; FLUORESCENCE; LIPID OXIDATION; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELLS, CULTURED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUORESCENCE; LIPOPROTEINS, LDL; MICROSCOPY, FLUORESCENCE; MOLECULAR STRUCTURE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIDATION-REDUCTION; PHOSPHOLIPID ETHERS; PHOSPHOLIPIDS; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33947164294     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600394-JLR200     Document Type: Article

References (70)

1. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
2. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
3. Berliner, J. A., M. Navab, A. M. Fogelman, J. S. Frank, L. L. Demer, P. A. Edwards, A. D. Watson, and A. J. Lusis. 1995. Atherosclerosis. Basic mechanisms: oxidation, inflammation, and genetics. Circulation. 91: 2488-2496.
4. Marathe, G. K., S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 2001. Oxidized LDL contains inflammatory PAF-like phospholipids. Trends Cardiovasc. Med. 11: 139-142.
5. Itabe, H., Y. Kushi, S. Handa, and K. Inoue. 1988. Identification of 2-azelaoylphosphatidylcholine as one of the cytotoxic products generated during oxyhemoglobin-induced peroxidation of phosphatidylcholine. Biochim. Biophys. Acta. 962: 8-15.
6. 2+/ascorbate/EDTA-induced lipid peroxidation. Biochim. Biophys. Acta. 1166: 264-274.
7. Leitinger, N., T. R. Tyner, L. Oslund, C. Rizza, G. Subbanagounder, H. Lee, P. T. Shih, N. Mackman, G. Tigyi, M. C. Territo, et al. 1999. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc. Natl. Acad. Sci. USA. 96: 12010-12015.
8. Watson, A. D., M. Navab, S. Y. Hama, A. Sevanian, S. M. Prescott, D. M. Stafforini, T. M. McIntyre, B. N. Du, A. M. Fogelman, and J. A. Berliner. 1995. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95: 774-782.
9. Subbanagounder, G., N. Leitinger, D. C. Schwenke, J. W. Wong, H. Lee, C. Rizza, A. D. Watson, K. F. Faull, A. M. Fogelman, and J. A. Berliner. 2000. Determinants of bioactivity of oxidized phospholipids: specific oxidized fatty acyl groups at the sn-2 position. Arterioscler. Thromb. Vasc. Biol. 20: 2248-2254.
10. Leitinger, N., A. D. Watson, K. F. Faull, A. M. Fogelman, and J. A. Berliner. 1997. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist. Adv. Exp. Med. Biol. 433: 379-382.
11. Loidl, A., E. Sevcsik, G. Riesenhuber, H. P. Deigner, and A. Hermetter. 2003. Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. J. Biol. Chem. 278: 32921-32928.
12. Watson, A. D., N. Leitinger, M. Navab, K. F. Faull, S. Horkko, J. L. Witztum, W. Palinski, D. Schwenke, R. G. Salomon, W. Sha, et al. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272: 13597-13607.
13. Itabe, H., E. Takeshima, H. Iwasaki, J. Kimura, Y. Yoshida, T. Imanaka, and T. Takano. 1994. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. J. Biol. Chem. 269: 15274-15279.
14. Horkko, S., D. A. Bird, E. Miller, H. Itabe, N. Leitinger, G. Subbanagounder, J. A. Berliner, P. Friedman, E. A. Dennis, L. K. Curtiss, et al. 1999. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103: 117-128.
15. Palinski, W., R. K. Tangirala, E. Miller, S. G. Young, and J. L. Witztum. 1995. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15: 1569-1576.
16. Palinski, W., S. Horkko, E. Miller, U. P. Steinbrecher, H. C. Powell, L. K. Curtiss, and J. L. Witztum. 1996. Cloning of monoclonal auto-antibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98: 800-814.
17. Kadl, A., J. Huber, F. Gruber, V. N. Bochkov, B. R. Binder, and N. Leitinger. 2002. Analysis of inflammatory gene induction by oxidized phospholipids in vivo by quantitative real-time RT-PCR in comparison with effects of LPS. Vascul. Pharmacol. 38: 219-227.
18. Reddy, S., S. Hama, V. Grijalva, K. Hassan, R. Mottahedeh, G. Hough, D. J. Wadleigh, M. Navab, and A. M. Fogelman. 2001. Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells. J. Biol. Chem. 276: 17030-17035.
19. Walton, K. A., A. L. Cole, M. Yeh, G. Subbanagounder, S. R. Krutzik, R. L. Modlin, R. M. Lucas, J. Nakai, E. J. Smart, D. K. Vora, et al. 2003. Specific phospholipid oxidation products inhibit ligand activation of Toll-like receptors 4 and 2. Arterioscler. Thromb. Vasc. Biol. 23: 1197-1203.
20. Ishikawa, K., M. Navab, N. Leitinger, A. M. Fogelman, and A. J. Lusis. 1997. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J. Clin. Invest. 100: 1209-1216.
21. Owens, G. K. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75: 487-517.
22. Pauletto, P., R. Sarzani, A. Rappelli, A. Chiavegato, A. C. Pessina, and S. Sartore. 1994. Differentiation and growth of vascular smooth muscle cells in experimental hypertension. Am. J. Hypertens. 7: 661-674.
23. Kogure, K., S. Nakashima, A. Tsuchie, A. Tokumura, and K. Fukuzawa. 2003. Temporary membrane distortion of vascular smooth muscle cells is responsible for their apoptosis induced by platelet-activating factor-like oxidized phospholipids and their degradation product, lysophosphatidylcholine. Chem. Phys. Lipids. 126: 29-38.
24. Dittmer, J. C., and R. L. Lester. 1964. A simple, specific spray for the detection of phospholipids on thin-layer chromatograms. J. Lipid Res. 15: 126-127.
25. Rouser, G., A. N. Siakotos, and S. Fleischer. 1966. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids. 1: 85-86.
26. Subbanagounder, G., A. D. Watson, and J. A. Berliner. 2000. Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities. Free Radic. Biol. Med. 28: 1751-1761.
27. Chung, B. H., T. Wilkinson, J. C. Geer, and J. P. Segrest. 1980. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J. Lipid Res. 21: 284-291.
28. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
29. Hofer, G., E. Steyrer, G. M. Kostner, and A. Hermetter. 1997. LDL-mediated interaction of Lp[a] with HepG2 cells: a novel fluorescence microscopy approach. J. Lipid Res. 38: 2411-2421.
30. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
31. Wessel, D., and U. I. Fluegge. 1984. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138: 141-143.
32. Bjellqvist, B., K. Ek, P. G. Righetti, E. Gianazza, A. Görg, R. Westermeier, and W. Postel. 1982. Isoelectric focusing in immobilized pH gradients: principle, methodology and some applications. J. Biochem. Biophys. Methods. 6: 317-339.
33. Bjellqvist, B., J-C. Sanchez, C. Pasquali, F. Ravier, N. Paquet, S. Frutiger, G. J. Hughes, and D. F. Hochstrasser. 1993. Micropreparative two-dimensional electrophoresis allowing separation of samples containingmilligramamounts of protein. Electrophoresis. 14: 1375-1378.
34. Sanchez, J-C., V. Rouge, M. Pisteur, F. Ravier, L. Tonella, M. Moosmayer, M. R. Wilkins, and D. F. Hochstrasser. 1997. Improved and simplified in-gel sample application using reswelling of dry immobilized pH gradients. Electrophoresis. 18: 324-327.
35. Görg, A., W. Postel, S. Günther, and J. Weser. 1985. Improved horizontal two-dimensional electrophoresis with hybrid isoelectric focusing in immobilized pH gradients in the first dimension and laying-on transfer to the second dimension. Electrophoresis. 6: 599-604.
36. Görg, A., W. Postel, and S. Günther. 1988. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis. 9: 531-546.
37. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
38. Zieseniss, S., S. Zahler, I. Muller, A. Hermetter, and B. Engelmann. 2001. Modified phosphatidylethanolamine as the active component of oxidized low density lipoprotein promoting platelet prothrombinase activity. J. Biol. Chem. 276: 19828-19835.
39. Friedman, P., S. Horkko, D. Steinberg, J. L. Witztum, and E. A. Dennis. 2002. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. importance of Schiff base formation and aldol condensation. J. Biol. Chem. 277: 7010-7020.
40. Kuhn, N., A. Kuhn, J. Lewandowski, and M. Speis. 1991. 1,2,3-Diazaborinium compounds-new cationic boron heteroarenes. Chem. Ber. 124: 2197-2201.
41. th edition.Molecular Probes, Inc., Eugene, OR.
42. Idziorek, T., J. Estaquier, F. De Bels, and J. C. Ameisen. 1995. YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J. Immunol. Methods. 185: 249-258.
43. Cohen, J. J. 1993. Apoptosis. Immunol. Today. 14: 126-130.
44. Foerster, T. 1969. Excimers. Angew. Chem. Int. Ed. Engl. 8: 333-343.
45. Hazen, S. L., J. Heller, F-F. Hsu, A. d'Avignon, and J. W. Heinecke. 1999. Synthesis, isolation, and characterization of the adduct formed in the reaction of p-hydroxyphenylacetaldehyde with the amino headgroup of phosphatidylethanolamine and phosphatidylserine. Chem. Res. Toxicol. 12: 19-27.
46. Naylor, B. L., M. Picardo, R. Homan, and H. J. Pownall. 1991. Effects of fluorophore structure and hydrophobicity on the uptake andmetabolismof fluorescent lipid analogs. Chem. Phys. Lipids. 58: 111-119.
47. Fruhwirth, G. O., A. Moumtzi, A. Loidl, E. Ingolic, and A. Hermetter. 2006. The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells. Biochim. Biophys. Acta. 1761: 1060-1069.
48. Struck, D. K., and R. E. Pagano. 1980. Insertion of fluorescent phospholipids into the plasma membrane of a mammalian cell. J. Biol. Chem. 255: 5404-5410.
49. Nichols, J. W., and R. E. Pagano. 1981. Kinetics of soluble lipid monomer diffusion between vesicles. Biochemistry. 20: 2783-2789.
50. Hamori, E., and A. M. Michaels. 1971. Determination of critical micelle concentration of aqueous lysolecithin solutions. Biochim. Biophys. Acta. 231: 496-504.
51. Esterbauer, H., R. J. Schaur, and H. Zollner. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11: 81-128.
52. Uchida, K., L. I. Szweda, H. Chae, and E. R. Stadtman. 1993. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc. Natl. Acad. Sci. USA. 90: 8742-8746.
53. Liu, W., A. A. Akhand, M. Kato, I. Yokoyama, T. Miyata, K. Kurokawa, K. Uchida, and I. Nakashima. 1999. 4-Hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J. Cell Sci. 112: 2409-2417.
54. Suc, I., O. Meilhac, I. Lajoie-Mazenc, J. Vandaele, G. Jurgens, R. Salvayre, and A. Negre-Salvayre. 1998. Activation of EGF receptor by oxidized LDL. FASEB J. 12: 665-671.
55. Gillotte, K. L., S. Horkko, J. L. Witztum, and D. Steinberg. 2000. Oxidized phospholipids, linked to apolipoprotein B of oxidized LDL, are ligands for macrophage scavenger receptors. J. Lipid Res. 41: 824-833.
56. Brown, M. S., and J. L. Goldstein. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 89: 331-340.
57. Podrez, E. A., G. Hoppe, J. O'Neil, and H. F. Hoff. 2003. Phospholipids in oxidized LDL not adducted to apoB are recognized by the CD36 scavenger receptor. Free Radic. Biol. Med. 34: 356-364.
58. Ahmed, Z., A. Ravandi, G. F. Maguire, A. Kuksis, and P. W. Connelly. 2003. Formation of apolipoprotein AI-phosphatidylcholine core aldehyde Schiff base adducts promotes uptake by THP-1 macrophages. Cardiovasc. Res. 58: 712-720.
59. Anderson, R. G. W. 1998. The caveolae membrane system. Annu. Rev. Biochem. 67: 199-225.
60. Kurzchalia, T. V., and R. G. Parton. 1999. Membrane microdomains and caveolae. Curr. Opin. Cell Biol. 11: 424-431.
61. Tillman, T. S., and M. Cascio. 2003. Effects of membrane lipids on ion channel structure and function. Cell Biochem. Biophys. 38: 161-190.
62. Simons, K., and G. van Meer. 1988. Lipid sorting in epithelial cells. Biochemistry. 27: 6197-6202.
63. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature. 387: 569-572.
64. Walton, K. A., X. Hsieh, N. Gharavi, S. Wang, G. Wang, M. Yeh, A. L. Cole, and J. A. Berliner. 2003. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8: a role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 278: 29661-29666.
65. Navab, M., J. A. Berliner, G. Subbanagounder, S. Hama, A. J. Lusis, L.W. Castellani, S. Reddy, D. Shih, W. Shi, A. D. Watson, et al. 2001. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 21: 481-488.
66. Heery, J. M., M. Kozak, D. M. Stafforini, D. A. Jones, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1995. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J. Clin. Invest. 96: 2322-2330.
67. Kern, H., T. Volk, S. Knauer-Schiefer, T. Mieth, B. Rustow, W. J. Kox, and M. Schlame. 1998. Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group. Biochim. Biophys. Acta. 1394: 33-42.
68. Smiley, P. L., K. E. Stremler, S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1991. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for plateletactivating factor. J. Biol. Chem. 266: 11104-11110.
69. Subbanagounder, G., N. Leitinger, P. T. Shih, K. F. Faull, and J. A. Berliner. 1999. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: in vitro and in vivo inhibition by WEB 2086. Circ. Res. 85: 311-318.
70. Watson, A. D., G. Subbanagounder, D. S. Welsbie, K. F. Faull, M. Navab, M. E. Jung, A. M. Fogelman, and J. A. Berliner. 1999. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein. J. Biol. Chem. 274: 24787-24798.